1. Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician Perspective

   • Susanne B. Nicholas
   • Eugene E. Wright
   • Terry Peeler

   Commentary Open access 25 October 2022 Pages: 1 - 18

   

2. Identifying Patients for Self-Administration of Omalizumab

   • Kevin R. Murphy
   • Tonya Winders
   • Bradley E. Chipps

   Commentary Open access 29 September 2022 Pages: 19 - 24

   

3. A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis

   • Haruki Koike
   • Ryoji Nishi
   • Masahisa Katsuno

   Review 24 September 2022 Pages: 25 - 40

   

4. Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review

   • Stefano Ballestri
   • Elisa Romagnoli
   • Mariano Capitelli

   Review Open access 16 October 2022 Pages: 41 - 66

   

5. Future Directions in Research in Transcriptomics in the Healing of Diabetic Foot Ulcers

   • Brandon J. Sumpio
   • Zhuqing Li
   • Aristidis Veves

   Review 20 October 2022 Pages: 67 - 75

   

6. The Importance of Integrated Regulation Mechanism of Coronary Microvascular Function for Maintaining the Stability of Coronary Microcirculation: An Easily Overlooked Perspective

   • Houyong Zhu
   • Hanxin Wang
   • Jinyu Huang

   Review 24 October 2022 Pages: 76 - 101

   

7. Peripheral T_reg Levels and Transforming Growth Factor-β (TGFβ) in Patients with Psoriatic Arthritis: A Systematic Review Meta-Analysis

   • Qin-Yi Su
   • Sheng-Xiao Zhang
   • Lei Shi

   Review 26 October 2022 Pages: 102 - 116

   

8. Recurrence Rates and Pharmacological Treatment for Hemorrhoidal Disease: A Systematic Review

   • Varut Lohsiriwat
   • Parvez Sheikh
   • Philippe Godeberge

   Review Open access 04 November 2022 Pages: 117 - 132

   

9. Safety of SABA Monotherapy in Asthma Management: a Systematic Review and Meta-analysis

   • Thitiwat Sriprasart
   • Grant Waterer
   • Gur Levy

   Review Open access 08 November 2022 Pages: 133 - 158

   

10. Educational and Emotional Needs of Patients with Myelodysplastic Syndromes: An AI Analysis of Multi-Country Social Media

    • Pauline P. Frank
    • Mabel X. E. Lu
    • Emma C. Sasse

    Original Research Open access 22 September 2022 Pages: 159 - 173

    

11. Development of an Assessment Tool for Completion by Patients with Overweight or Obesity

    • Nina Kim
    • T. Michelle Brown
    • Ronette L. Kolotkin

    Original Research Open access 18 October 2022 Pages: 174 - 193

    

12. Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus

    • Jas Bindra
    • Ishveen Chopra
    • George J. Wan

    Original Research Open access 20 October 2022 Pages: 194 - 210

    

13. Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up

    • Mustafa N. Yenerel
    • Flore Sicre de Fontbrune
    • Jeff Szer

    Original Research Open access 22 October 2022 Pages: 211 - 232

    

14. European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction

    • Nadeem Qureshi
    • Sotiris Antoniou
    • José R. González-Juanatey

    Original Research Open access 26 October 2022 Pages: 233 - 251

    

15. A Two-Step, Trajectory-Focused, Analytics Approach to Attempt Prediction of Analgesic Response in Patients with Moderate-to-Severe Osteoarthritis

    • Joanna Atkinson
    • Roger A. Edwards
    • Thomas J. Schnitzer

    Original Research 27 October 2022 Pages: 252 - 264

    

16. Projecting the Epidemiological and Economic Impact of Chronic Kidney Disease Using Patient-Level Microsimulation Modelling: Rationale and Methods of Inside CKD

    • Navdeep Tangri
    • Steven Chadban
    • Juan José García Sánchez

    Original Research Open access 28 October 2022 Pages: 265 - 281

    

17. Examining the Systemic Bioavailability of Cannabidiol and Tetrahydrocannabinol from a Novel Transdermal Delivery System in Healthy Adults: A Single-Arm, Open-Label, Exploratory Study

    • Gyula Varadi
    • Zhen Zhu
    • Malkanthi Evans

    Original Research Open access 29 October 2022 Pages: 282 - 293

    

18. Advances in Delivery of Selective Internal Radiation Therapy (SIRT): Economic and Logistical Effects of Same-Stay Work-Up and Procedure in the Treatment of Unresectable Liver Tumors in England

    • Richard F. Pollock
    • Suki Shergill
    • Victoria K. Brennan

    Original Research Open access 01 November 2022 Pages: 294 - 309

    

19. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer

    • Jian Zheng
    • Yi-Fan Zhang
    • Ji-Min Cao

    Original Research 01 November 2022 Pages: 310 - 330

    

20. Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer in the United States, Europe, and Israel

    • Reshma Mahtani
    • Alexander Niyazov
    • Michael P. Lux

    Original Research Open access 28 October 2022 Pages: 331 - 348

    

21. Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation

    • Matthew C. Dickson
    • Michael M. Nguyen
    • Grant H. Skrepnek

    Original Research Open access 08 November 2022 Pages: 349 - 366

    

22. No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab

    • Andrew Blauvelt
    • Andreas Wollenberg
    • Sonya L. Cyr

    Brief Report Open access 01 November 2022 Pages: 367 - 380

    

23. Response to: Letter to the Editor Regarding Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM

    • Yuji Kawaguchi
    • Yuriko Hajika
    • Yasuro Kumeda

    Letter 19 October 2022 Pages: 381 - 382

24. Letter to the Editor Regarding Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM

    • Yuki Oe
    • Hiroshi Nomoto
    • Tatsuya Atsumi

    Letter 28 October 2022 Pages: 383 - 386

25. Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting

    • Brooke Harrow
    • Francis Fagnani
    • Louis de Mestier

    Correction Open access 31 October 2022 Pages: 387 - 388

26. Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

    • Gregory R. Fulcher
    • Shahid Akhtar
    • Adri Kok

    Correction Open access 31 October 2022 Pages: 389 - 390

27. Correction to: Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed

    • Leslie Citrome
    • Robert Risinger
    • Heather Robison

    Correction Open access 31 October 2022 Pages: 391 - 391